Work

P738 NO CLINICALLY RELEVANT DRUG–DRUG INTERACTIONS BETWEEN FALDAPREVIR AND PEGYLATED INTERFERON a-2a PLUS RIBAVIRIN IN HCV-INFECTED PATIENTS: PHARMACOKINETIC ANALYSES FROM TWO PHASE II STUDIES

Year: 2014

Type: conference-abstract

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(14)60899-0

Authors: M. Bourlière, M. Sulkowski, M.P. Manns, T. Asselah, P. Ferenci, S. Pol, T. Berg, J. Lalezari, A.-M. Quinson, Y. Datsenko, J. Scherer, C.-L. Yong, F. Huang

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1991787310

Cites:

Cited by:

Related to: 10